CAS RN: 28447-39-4
Allolactose
Product Availability
Choose a grade to view its available package options.
4 package records1 with current stock1 grade group
| Batch No. | Package | Availability | Inquiry |
| Batchno.20250507 |
10mg |
In stock |
Inquiry |
| Batchno.20251026 |
25mg |
Out of stock |
Inquiry |
| Batchno.20250531 |
50mg |
Out of stock |
Inquiry |
| Batchno.20250213 |
5mg |
Out of stock |
Inquiry |
-
Product code:
ICTA2630
-
Purity/Analytical Methods:
>98.0%(HPLC)
GET A QUOTE
28447-39-4 / 6-[[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxane-2,3,4,5-tetrol
Standard CAS: 28447-39-4
Multi CAS: Yes
Basic Information
CAS
28447-39-4
Multi CAS
Yes
Molecular Formula
C12H22O11
Molecular Weight
342.300000
Exact Mass
342.116212
InChI
InChI=1S/C12H22O11/c13-1-3-5(14)8(17)10(19)12(23-3)21-2-4-6(15)7(16)9(18)11(20)22-4/h3-20H,1-2H2
InChIKey
DLRVVLDZNNYCBX-UHFFFAOYSA-N
Computed Properties
Structural Parameters
Heavy atom count
23
Fraction Csp3
1
Rotatable bonds
4
H-bond acceptors
11
H-bond donors
8
Molar refractivity
68.62
TPSA
189.53
LogP / Solubility
WLOGP
-5.4
MLOGP
-4.73
XLogP3
-4.7
Consensus LogP
-4.94
Log S (ESOL)
1.7
Class (ESOL)
Highly soluble
Log S (Ali)
1.53
Class (Ali)
Highly soluble
Log S (SILICOS-IT)
2.11
Class (SILICOS-IT)
Highly soluble
ADME
GI absorption
Low
BBB permeant
No
P-gp substrate
No
CYP1A2 inhibitor
No
CYP2C19 inhibitor
No
CYP2C9 inhibitor
No
CYP2D6 inhibitor
No
CYP3A4 inhibitor
No
Log Kp (skin permeation)
-8.64
Drug-likeness / Medicinal Chemistry
Lipinski
No
Ghose
No
Veber
No
Egan
No
Muegge
No
Bioavailability score
0.17
Leadlikeness
Yes
Synthetic Accessibility
7.5